Annual CFF
-$2.30 M
-$3.81 M-251.68%
31 December 2023
Summary:
Castle Biosciences annual cash flow from financing activities is currently -$2.30 million, with the most recent change of -$3.81 million (-251.68%) on 31 December 2023. During the last 3 years, it has fallen by -$308.19 million (-100.75%). CSTL annual CFF is now -100.75% below its all-time high of $305.89 million, reached on 31 December 2020.CSTL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$838.00 K
+$796.00 K+1895.24%
30 September 2024
Summary:
Castle Biosciences quarterly cash flow from financing activities is currently $838.00 thousand, with the most recent change of +$796.00 thousand (+1895.24%) on 30 September 2024. Over the past year, it has increased by +$793.00 thousand (+1762.22%). CSTL quarterly CFF is now -99.63% below its all-time high of $227.82 million, reached on 31 December 2020.CSTL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$8.23 M
+$793.00 K+10.67%
30 September 2024
Summary:
Castle Biosciences TTM cash flow from financing activities is currently $8.23 million, with the most recent change of +$793.00 thousand (+10.67%) on 30 September 2024. Over the past year, it has increased by +$7.98 million (+3204.02%). CSTL TTM CFF is now -97.32% below its all-time high of $306.84 million, reached on 31 March 2021.CSTL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -251.7% | +1762.2% | +3204.0% |
| 3 y3 years | -100.8% | -55.8% | -96.5% |
| 5 y5 years | -114.5% | -98.9% | -91.1% |
CSTL Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.8% | at low | -92.1% | +125.4% | -96.5% | +458.0% |
| 5 y | 5 years | -100.8% | at low | -99.6% | +125.4% | -97.3% | +458.0% |
| alltime | all time | -100.8% | at low | -99.6% | +125.4% | -97.3% | +458.0% |
Castle Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $838.00 K(+1895.2%) | $8.23 M(+10.7%) |
| June 2024 | - | $42.00 K(-99.6%) | $7.43 M(-2.4%) |
| Mar 2024 | - | $10.64 M(-422.8%) | $7.62 M(-431.5%) |
| Dec 2023 | -$2.30 M(-251.7%) | -$3.30 M(-7426.7%) | -$2.30 M(-1022.9%) |
| Sept 2023 | - | $45.00 K(-80.1%) | $249.00 K(-57.9%) |
| June 2023 | - | $226.00 K(-69.0%) | $592.00 K(-42.4%) |
| Mar 2023 | - | $728.00 K(-197.1%) | $1.03 M(-32.2%) |
| Dec 2022 | $1.51 M(-72.1%) | -$750.00 K(-293.3%) | $1.51 M(-36.6%) |
| Sept 2022 | - | $388.00 K(-41.3%) | $2.39 M(-38.6%) |
| June 2022 | - | $661.00 K(-45.6%) | $3.90 M(-24.0%) |
| Mar 2022 | - | $1.22 M(+865.1%) | $5.13 M(-5.4%) |
| Dec 2021 | $5.42 M | $126.00 K(-93.3%) | $5.42 M(-97.7%) |
| Sept 2021 | - | $1.89 M(+0.2%) | $233.12 M(-2.6%) |
| June 2021 | - | $1.89 M(+25.2%) | $239.37 M(-22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $1.51 M(-99.3%) | $306.84 M(+0.3%) |
| Dec 2020 | $305.89 M(+246.5%) | $227.82 M(+2695.3%) | $305.89 M(+290.7%) |
| Sept 2020 | - | $8.15 M(-88.2%) | $78.29 M(-46.6%) |
| June 2020 | - | $69.36 M(>+9900.0%) | $146.56 M(+87.6%) |
| Mar 2020 | - | $559.00 K(+149.6%) | $78.14 M(-11.5%) |
| Dec 2019 | $88.29 M(+457.4%) | $224.00 K(-99.7%) | $88.29 M(-4.5%) |
| Sept 2019 | - | $76.42 M(+8064.6%) | $92.48 M(+474.5%) |
| June 2019 | - | $936.00 K(-91.3%) | $16.10 M(-24.1%) |
| Mar 2019 | - | $10.71 M(+142.3%) | $21.20 M(+33.8%) |
| Dec 2018 | $15.84 M(+78.6%) | $4.42 M(>+9900.0%) | $15.84 M(+38.7%) |
| Sept 2018 | - | $36.60 K(-99.4%) | $11.42 M(+0.3%) |
| June 2018 | - | $6.04 M(+12.8%) | $11.38 M(+112.8%) |
| Mar 2018 | - | $5.35 M | $5.35 M |
| Dec 2017 | $8.87 M | - | - |
FAQ
- What is Castle Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Castle Biosciences?
- What is Castle Biosciences annual CFF year-on-year change?
- What is Castle Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Castle Biosciences?
- What is Castle Biosciences quarterly CFF year-on-year change?
- What is Castle Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Castle Biosciences?
- What is Castle Biosciences TTM CFF year-on-year change?
What is Castle Biosciences annual cash flow from financing activities?
The current annual CFF of CSTL is -$2.30 M
What is the all time high annual CFF for Castle Biosciences?
Castle Biosciences all-time high annual cash flow from financing activities is $305.89 M
What is Castle Biosciences annual CFF year-on-year change?
Over the past year, CSTL annual cash flow from financing activities has changed by -$3.81 M (-251.68%)
What is Castle Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of CSTL is $838.00 K
What is the all time high quarterly CFF for Castle Biosciences?
Castle Biosciences all-time high quarterly cash flow from financing activities is $227.82 M
What is Castle Biosciences quarterly CFF year-on-year change?
Over the past year, CSTL quarterly cash flow from financing activities has changed by +$793.00 K (+1762.22%)
What is Castle Biosciences TTM cash flow from financing activities?
The current TTM CFF of CSTL is $8.23 M
What is the all time high TTM CFF for Castle Biosciences?
Castle Biosciences all-time high TTM cash flow from financing activities is $306.84 M
What is Castle Biosciences TTM CFF year-on-year change?
Over the past year, CSTL TTM cash flow from financing activities has changed by +$7.98 M (+3204.02%)